Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01075256 · ClinicalTrials.gov registry record · Phase 4
Dose Response of a Tubule Occlusion Agent
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 195
- Enrollment target
NCT01075256 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 195 participants.
The verdict
NCT01075256, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 195 participants
- Enrollment target
Study Summary
To evaluate the efficacy of two different concentrations of a tubule occlusion agent - calcium sodium phosphosilicate in treatment of dentine hypersensitivity
Interventions
- DEVICE 5% calcium sodium phosphosilicate toothpaste
- DEVICE 7.5% calcium sodium phosphosilicate toothpaste
- DEVICE Placebo toothpaste
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01075256
The ClinicalTrials.gov registry entry for NCT01075256 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 5% calcium sodium phosphosilicate toothpaste is the first listed.
NCT01075256 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01075256 about?
NCT01075256 is a clinical study titled "Dose Response of a Tubule Occlusion Agent". To evaluate the efficacy of two different concentrations of a tubule occlusion agent - calcium sodium phosphosilicate in treatment of dentine hypersensitivity
What is the current status of trial NCT01075256?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 195 participants. The study started on 2008-12. Estimated completion is 2009-03.
What interventions are being tested in trial NCT01075256?
The interventions under investigation include: 5% calcium sodium phosphosilicate toothpaste (DEVICE), 7.5% calcium sodium phosphosilicate toothpaste (DEVICE), Placebo toothpaste (DEVICE).
Who is sponsoring clinical trial NCT01075256?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.